Cargando…

SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread

BACKGROUND: The Corona virus disease 2019 (COVID-19) pandemic caused by SARS -Corona virus-2 (SARS-CoV-2) has been a major concern the world over. Serological surveillance is an important tool to assess the spread of infection in the community. This study attempted to assess the prevalence of antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kale, Pratibha, Patel, Niharika, Gupta, Ekta, Bajpai, Meenu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516133/ https://www.ncbi.nlm.nih.gov/pubmed/34686444 http://dx.doi.org/10.1016/j.transci.2021.103293

Ejemplares similares

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Bajpai, Vijeta, et al.
Publicado: (2021)

Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
por: Pandey, Hem Chandra, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence in Delhi, India, During September-October 2021: A Population-Based Seroepidemiological Study
por: Sharma, Pragya, et al.
Publicado: (2022)

Delayed adverse reactions in whole blood donors: Importance of active surveillance in identifying the missing gaps in the donor safety
por: Gupta, Abhaykumar Malind, et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures
por: Barzin, Amir, et al.
Publicado: (2020)

Automation in Immunohematology
por: Bajpai, Meenu, et al.
Publicado: (2012)

Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays
por: Gupta, Ekta, et al.
Publicado: (2014)

Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
por: Kale, Pratibha, et al.
Publicado: (2021)

The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
por: Younas, Amber, et al.
Publicado: (2020)

Comparative assessment of single-donor plateletpheresis by Haemonetics(®) MCS(®) plus and Trima Accel(®)
por: Baruah, Sukanya, et al.
Publicado: (2020)

Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
por: Kaur, Savneet, et al.
Publicado: (2021)

Dengue seroprevalence among asymptomatic blood donors during an epidemic outbreak in Central-West Brazil
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2019)

Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City
por: Ashshi, Ahmed M, et al.
Publicado: (2017)

High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia
por: Alzabeedi, Kamal H., et al.
Publicado: (2022)

Diagnostic dilemmas in human immunodeficiency virus testing
por: Choudhary, Aashish, et al.
Publicado: (2014)

P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India
por: Patel, Niharika, et al.
Publicado: (2022)

Seroprevalence of six pathogens transmitted by the Ixodes ricinus ticks in asymptomatic individuals with HIV infection and in blood donors
por: Pawełczyk, Agnieszka, et al.
Publicado: (2019)

Dengue Seroprevalence of Healthy Adults in Singapore: Serosurvey among Blood Donors, 2009
por: Low, Swee-Ling, et al.
Publicado: (2015)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
por: Sebastião, Cruz S., et al.
Publicado: (2021)

Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt
por: Gad, Yahia Z., et al.
Publicado: (2011)

Seroprevalence and risk factors for infection with equine coronavirus in healthy horses in the USA
por: Kooijman, L.J., et al.
Publicado: (2017)

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
por: Sughayer, Maher A., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study
por: Jaiswal, Ram, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Ng, Dianna L., et al.
Publicado: (2020)

Tracking SARS-CoV-2 seroprevalence among Canadian blood donors
por: Saeed, Sahar, et al.
Publicado: (2022)

Seroprevalence of Chagas Infection in the Donor Population
por: Zaniello, Ben A., et al.
Publicado: (2012)

Current perspectives on the spread of dengue in India
por: Gupta, Ekta, et al.
Publicado: (2014)

Seroprevalence and Risk Factors for Exposure to Equine Coronavirus in Apparently Healthy Horses in Israel
por: Schvartz, Gili, et al.
Publicado: (2021)

Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update
por: Kalmár, Zsuzsa, et al.
Publicado: (2021)

Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
por: Leister, Iris, et al.
Publicado: (2021)

Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
por: O’Brien, Sheila F., et al.
Publicado: (2022)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
por: Ferrari, Martina, et al.
Publicado: (2023)

Hepatitis E seroprevalence among blood donors: A pilot study from Western India
por: Gajjar, Maitrey D., et al.
Publicado: (2014)

COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population
por: Breedon, Amy M. E., et al.
Publicado: (2021)

Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysis
por: Sharma, Pragya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8oma1tgb3r8a76goc7iapva2i